DEM BIOPHARMA
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
DEM BIOPHARMA
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2022-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.dembiopharma.com
Total Employee:
1+
Status:
Active
Total Funding:
70 M USD
Current Advisors List
Investors List
Emerson Collective
Emerson Collective investment in Series A - DEM BioPharma
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Series A - DEM BioPharma
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - DEM BioPharma
Astellas Venture Management
Astellas Venture Management investment in Series A - DEM BioPharma
Alta Partners
Alta Partners investment in Series A - DEM BioPharma
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - DEM BioPharma
Longwood Fund
Longwood Fund investment in Series A - DEM BioPharma
Insight Partners
Insight Partners investment in Series A - DEM BioPharma
Official Site Inspections
http://www.dembiopharma.com Semrush global rank: 7.52 M Semrush visits lastest month: 462
- Host name: host.cmm-clients.com
- IP address: 108.160.150.150
- Location: Baltimore United States
- Latitude: 39.2645
- Longitude: -76.6224
- Metro Code: 512
- Timezone: America/New_York
- Postal: 21230
More informations about "DEM BioPharma"
DEM BioPharma – Unleashing the power of the innate …
Jan is a member of the Board of Directors at Zentalis Pharmaceuticals (Nasdaq:ZNTL), and Monte Rosa Therapeutics (Nasdaq:GLUE). Previously, he was the CEO of Trillium Therapeutics (Nasdaq:TRIL), a clinical stage immuno …See details»
DEM BioPharma Company Profile 2024: Valuation, …
DEM BioPharma General Information Description. Developer of an immunotherapeutics platform designed to pioneer the next generation of …See details»
DEM BioPharma - Crunchbase Company Profile
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints. View contacts …See details»
DEM Biopharma, Inc. - Org Chart, Teams, Culture & Jobs - The Org
View DEM Biopharma, Inc.'s up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
DEM Biopharma, Inc. | LinkedIn
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) …See details»
DEM Biopharma, Inc. - Company Profile & Staff Directory
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) …See details»
Dem Biopharma - Overview, News & Similar companies
View Dem Biopharma (www.dembiopharma.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
DEM BioPharma Company Profile: Overview and Full News Analysis
Dembiopharma.com. Overview: DEM BioPharma. DEM BioPharma, located in Massachusetts, is a pioneering company focused on unleashing the power of the innate immune system to …See details»
DEM BioPharma - Craft
DEM BioPharma is a company that works to eradicate cancer by targeting new checkpoints in the innate immune system.See details»
DEM BioPharma Launches with $70 Million Financing
%PDF-1.6 %âãÏÓ 79 0 obj > endobj 106 0 obj >/Filter/FlateDecode/ID[]/Index[79 46]/Info 78 0 R/Length 123/Prev 226521/Root 80 0 R/Size 125/Type/XRef/W[1 3 1 ...See details»
DEM Biopharma, Inc. Company Overview, Contact Details
Cutting-Edge Immunotherapeutics DEM Biopharma is revolutionizing cancer treatment through advanced immunotherapeutics that target specific signals on cancer cells and immune …See details»
DEM Bio LT Announcement Release_Final 092622.docx
DEM Bio is pioneering the next generation of immunotherapeutics that unleash the innate immune system to eliminate tumors by targeting ‘don’t eat me’ (DEM) and ‘eat me’ (EM) signals on …See details»
Dem BioPharma Inc. - BioCentury Company Profiles - BCIQ
Mar 23, 2023 Dem BioPharma Inc. - BioCentury Company Profiles for the biopharma industrySee details»
DEM BioPharma CEO and Key Executive Team | Craft.co
DEM BioPharma's Executive Chairman is Jan Skvarka. Other executives include David Donabedian, Co-founder, Start-up CEO, & Director; John McCabe, CFO/COO and 4 others. …See details»
DEM BioPharma - workinbiotech.com
DEM Biopharma aims to develop immunotherapies that will trigger macrophages and myeloid cells to eliminate tumors by recognizing “don’t eat me” (DEM) and “eat me” (EM) signals on …See details»
DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific …
DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board . CAMBRIDGE, Mass., June 13, 2023-- DEM BioPharma, Inc. (DEM Bio), an immune-oncologySee details»
DEM BioPharma - VentureRadar
DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and …See details»
DEM BioPharma Establishes Leadership Team with ... - Business Wire
Sep 27, 2022 DEM BioPharma established its C-suite and scientific leadership teams with the appointment of Nenad Grmusa as CEO and Christophe Quéva, Ph.D., as CSO.See details»
CRISPR-, Macrophage-Focused DEM BioPharma Launches with …
Jun 27, 2022 The three co-founding scientist of DEM are: Jonathan Weissman, Ph.D.—Whitehead Institute, and a renowned researchers in genome-wide CRISPR screens;; …See details»
DEM BioPharma Appoints Miriam Merad, M.D., Ph.D., to Scientific ...
Mar 13, 2023 DEM BioPharma Appoints Miriam Merad, M.D., Ph.D., to Scientific Advisory Board . CAMBRIDGE, Mass., March 14, 2022-- DEM BioPharma, Inc. (DEM Bio), an immune …See details»